20 October 2020

Oxford PharmaGenesis supports CISCRP's Patient Diversity Campaign

Oxford PharmaGenesis is proud to support CISCRP in a new educational initiative to increase awareness and understanding of clinical research among minority urban communities. We have collaborated with CISCRP to sponsor an advertisement that highlights the key importance of diversity among participants in clinical studies in order to discover treatments that are effective for everyone. (more details)

Continue reading

19 October 2020

Highlights from World Pharma Pricing Market Access & Evidence Congress 2020

The annual World Pharma Pricing Market Access & Evidence congress was held on 23–25 September 2020 for the first time in a virtual environment, and was attended by members of our Value Demonstration Practice.

Continue reading

9 October 2020

World Mental Health Day 2020

Mental health for all. Greater investment – greater access. Everyone, everywhere.

Oxford PharmaGenesis is committed to ensuring good mental health and well-being for all of its employees, offering access to support services, training and other valuable resources. We also host a team of trained Mental Health First Aiders (MHFAs) who serve as a point of contact for any of our global colleagues who may be experiencing a mental health issue.

Continue reading

29 September 2020

Putting the patient first: Pharma & Patient Europe 2020

Oxford PharmaGenesis was delighted to attend the recent eyeforpharma Patient Summit 2020 earlier this month. As part of the ‘new normal’, the meeting this year was virtual, and content was available on demand. This allowed multiple members of the Patient Engagement Team to attend and gain insights on the latest in the patient engagement field. In addition, Sarah Griffiths co-moderated a roundtable discussion with Alan Thomas of Ataxia and Me. The topic of ‘How to move from ad-hoc to continuous dialogue with patients’ was discussed in depth, with animated and engaging conversations between multiple patient advocates and pharma representatives.

Continue reading

25 September 2020

International Ataxia Awareness Day: in conversation with Alan from Ataxia and Me

Alan Thomas is a patient advocate for rare diseases, and ataxia in particular. He is known as the ‘rare disease warrior’ and, as a patient with a life-limiting rare disease, he can convey the patient engagement message from his point of view on all issues regarding the wellbeing of patients.

Continue reading

14 September 2020

What makes Oxford PharmaGenesis the perfect environment for early-career professionals?

After finishing my undergraduate degree in biomedical sciences, I was eager to harness the skills I had developed and transfer them to a new environment. This led me to apply for an internship at Oxford PharmaGenesis.

Continue reading
1 2 3 30